Pharmacological strategies targeting oxidative injury and cell death show potential for intestinal ischemia reperfusion injuryNew Pharmacological Strategies Show Potential for Intestinal Ischemia Injury

This narrative review synthesizes the therapeutic potential of various pharmacological interventions for intestinal ischemia and reperfusion injury. The scope includes agents targeting oxidative stress, inflammation, and dysregulated cell death, such as thiol compounds, polyphenols, melatonin, SIRT-axis modulators, and anti-inflammatory agents. Additionally, the review examines ferroptosis and autophagy modulators alongside targeted delivery platforms to improve clinical outcomes.

The authors conclude that these compounds show potential in mitigating microcirculatory dysfunction and barrier failure. Specifically, the review highlights the roles of thiol compounds and polyphenols in addressing the physiological damage caused by ischemia. However, the authors emphasize that the evidence base is currently limited by the use of heterogeneous animal models.

Clinical application is currently constrained by a lack of robust human data. The review notes that while these mechanisms are promising, the transition from experimental models to clinical practice requires more rigorous investigation. Practitioners should interpret these findings as preliminary, as the current evidence is not sufficient to establish definitive clinical protocols for intestinal ischemia management.